dc.contributor.author |
Tritek, V.
|
|
dc.contributor.author |
Zhaugasheva, S.K.
|
|
dc.contributor.author |
Gulyayev, A.
|
|
dc.contributor.author |
Sergazy, Sh.
|
|
dc.contributor.author |
Khassenbekova, Zh.
|
|
dc.contributor.author |
Yermekbayeva, B.
|
|
dc.contributor.author |
Nurgozhin, T.
|
|
dc.creator |
V., Tritek |
|
dc.date.accessioned |
2017-12-14T06:09:52Z |
|
dc.date.available |
2017-12-14T06:09:52Z |
|
dc.date.issued |
2017-08-01 |
|
dc.identifier |
DOI:10.1016/j.clinthera.2017.05.244 |
|
dc.identifier.citation |
V. Tritek, S.K. Zhaugasheva, A. Gulyayev, Sh. Sergazy, Zh. Khassenbekova, B. Yermekbayeva, T. Nurgozhin, Possible Changes of Pharmacokinetics of IL-2 Deposited in Red Blood Cells (RBC), In Clinical Therapeutics, Volume 39, Issue 8, Supplement, 2017, Page e79 |
|
dc.identifier.issn |
01492918 |
|
dc.identifier.uri |
https://www.sciencedirect.com/science/article/pii/S0149291817305428 |
|
dc.identifier.uri |
http://nur.nu.edu.kz/handle/123456789/2895 |
|
dc.relation.ispartof |
Clinical Therapeutics |
|
dc.title |
Possible Changes of Pharmacokinetics of IL-2 Deposited in Red Blood Cells (RBC) |
|
dc.type |
Article |
|
dc.rights.license |
Copyright © 2017 Published by Elsevier Inc. |
|
dcterms.publisher |
Clinical Therapeutics |
|
elsevier.identifier.doi |
10.1016/j.clinthera.2017.05.244 |
|
elsevier.identifier.eid |
1-s2.0-S0149291817305428 |
|
elsevier.identifier.pii |
S0149-2918(17)30542-8 |
|
elsevier.volume |
39 |
|
elsevier.issue.identifier |
8 |
|
elsevier.issue.name |
The Proceedings of the 13th Congress of the European Association for Clinical Pharmacology and Therapeutics |
|
elsevier.coverdate |
2017-08-01 |
|
elsevier.coverdisplaydate |
August 2017 |
|
elsevier.startingpage |
e79 |
|
elsevier.openaccess |
0 |
|
elsevier.openaccessarticle |
false |
|
elsevier.openarchivearticle |
false |
|
elsevier.aggregationtype |
Journal |
|